  Traumatic brain injury ( TBI) is a major public health problem estimated to affect nearly 1.7 million people in the United States annually. Due to the often debilitating effects of TBI , novel preventative agents are highly desirable for at risk populations. Here , we tested a whey protein supplement , Immunocal ® , for its potential to enhance resilience to TBI. Immunocal ® is a non-denatured whey protein preparation which has been shown to act as a cysteine delivery system to increase levels of the essential antioxidant glutathione ( GSH). Twice daily oral supplementation of CD1 mice with Immunocal